← Issue №10/ week of Sep 6, 2026/Endoscopy

Performance, Efficacy, and Safety of Lubiprostone in Bowel Preparation Regimens: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

From GI Signals issue №10: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Endoscopy meta analysis · n=1,322 · Sep 1, 2026 · J Clin Gastro · IF 2.9

Performance, Efficacy, and Safety of Lubiprostone in Bowel Preparation Regimens: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

New evidencecolonoscopysystematic reviewmeta-analysis
Clinical takeawayConsider lubiprostone adjunct for patients undergoing colonoscopy, given its higher excellent prep rates without added risk, though it does not improve polyp detection.
What it foundLubiprostone adjunct bowel prep doubled excellent prep rates (OR 2.25, 95% CI 1.52-3.33) and reduced poor prep (P=0.009) compared to standard prep alone, with no difference in polyp detection, duration, or adverse events.
ContextConfirms lubiprostone's role in improving prep quality, a known challenge in colonoscopy, without altering detection or safety compared to standard prep.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Wu Y … Han A · Journal of Clinical Gastroenterology · IF 2.9 · PubMed ↗Permalink
← Read the whole of issue №10 Every paper GI Signals surfaces gets a page like this one. All issues